» Articles » PMID: 39958876

Something to Talk About; Crosstalk Disruption at the Neurovascular Unit During HIV Infection of the CNS

Overview
Date 2025 Feb 17
PMID 39958876
Authors
Affiliations
Soon will be listed here.
Abstract

Although treatable with antiretroviral therapy, HIV infection persists in people living with HIV (PLWH). It is well known that the HIV virus finds refuge in places for which antiretroviral medications do not reach therapeutic levels, mainly the CNS. It is clear that as PLWH age, the likelihood of developing HIV-associated neurological deficits increases. At the biochemical level neurological dysfunction is the manifestation of altered cellular function and ineffective intercellular communication. In this review, we examine how intercellular signaling in the brain is disrupted in the context of HIV. Specifically, the concept of how the blood-brain barrier can be a convergence point for crosstalk, is explored. Crosstalk between the cells of the neurovascular unit (NVU) (endothelium, pericytes, astrocytes, microglia and neurons) is critical for maintaining proper brain function. In fact, the NVU allows for rapid matching of neuronal metabolic needs, regulation of blood-brain barrier (BBB) dynamics for nutrient transport and changes to the level of immunosurveillance. This review invites the reader to conceptually consider the BBB as a router or convergence point for NVU crosstalk, to facilitate a better understanding of the intricate signaling events that underpin the function of the NVU during HIV associated neuropathology.

References
1.
Rosenberg G . Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab. 2012; 32(7):1139-51. PMC: 3390801. DOI: 10.1038/jcbfm.2011.197. View

2.
King J, Eugenin E, Hazleton J, Morgello S, Berman J . Mechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for neuroAIDS pathogenesis. Am J Pathol. 2010; 176(6):2819-30. PMC: 2877843. DOI: 10.2353/ajpath.2010.090642. View

3.
Langford D, Adame A, Grigorian A, Grant I, McCutchan J, Ellis R . Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr. 2003; 34(5):467-74. DOI: 10.1097/00126334-200312150-00004. View

4.
Dudvarski Stankovic N, Teodorczyk M, Ploen R, Zipp F, Schmidt M . Microglia-blood vessel interactions: a double-edged sword in brain pathologies. Acta Neuropathol. 2015; 131(3):347-63. DOI: 10.1007/s00401-015-1524-y. View

5.
Narvid J, Mccoy D, Dupont S, Callen A, Tosun D, Hellmuth J . Abnormal Cerebral Perfusion Profile in Older Adults with HIV-Associated Neurocognitive Disorder: Discriminative Power of Arterial Spin-Labeling. AJNR Am J Neuroradiol. 2018; 39(12):2211-2217. PMC: 6748330. DOI: 10.3174/ajnr.A5902. View